Ac-LEHD-AFC

What We Offer

Ac-LEHD-AFC

Ac-LEHD-AFC | CAS 210345-03-2

Catalog Number A18-0001
Category Fluorescent Enzyme Substrates
Molecular Formula C33H38F3N7O11
Molecular Weight 765.69
Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Introduction

Ac-LEHD-AFC is a widely recognized fluorogenic substrate used in the study of caspase-9 activity during apoptosis research. This compound undergoes cleavage by caspase-9, releasing the fluorescent molecule AFC, which can be quantitatively measured to assess enzymatic activity. Researchers utilize Ac-LEHD-AFC to investigate the intricate mechanisms of programmed cell death and the role of caspases in cellular processes. Its application is crucial in understanding biochemical pathways and cellular responses to apoptotic signals.

  • Chemical Information

  • Product Specification

  • Application

  • Computed Properties

  • Patents

Synonyms N-acetyl-L-leucyl-L-α-glutamyl-L-histidyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]-L-α-asparagine; N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin; Caspase-9 substrate; L-α-Asparagine, N-acetyl-L-leucyl-L-α-glutamyl-L-histidyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]-; (4S,7S,10S,13S)-10-((1H-imidazol-5-yl)methyl)-7-(2-carboxyethyl)-4-isobutyl-2,5,8,11-tetraoxo-13-((2-oxo-4-(trifluoromethyl)-2H-chromen-7-yl)carbamoyl)-3,6,9,12-tetraazapentadecan-15-oic acid
Purity ≥95%
IUPAC Name (4S)-4-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S)-3-carboxy-1-oxo-1-[[2-oxo-4-(trifluoromethyl)chromen-7-yl]amino]propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Canonical SMILES CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)O)C(=O)NC2=CC3=C(C=C2)C(=CC(=O)O3)C(F)(F)F)NC(=O)C
InChI InChI=1S/C33H38F3N7O11/c1-15(2)8-22(39-16(3)44)31(52)41-21(6-7-26(45)46)29(50)42-23(9-18-13-37-14-38-18)32(53)43-24(12-27(47)48)30(51)40-17-4-5-19-20(33(34,35)36)11-28(49)54-25(19)10-17/h4-5,10-11,13-15,21-24H,6-9,12H2,1-3H3,(H,37,38)(H,39,44)(H,40,51)(H,41,52)(H,42,50)(H,43,53)(H,45,46)(H,47,48)
InChIKey HULKIXRFKRCRHD-ZJZGAYNASA-N
Solubility Soluble in DMF, DMSO
Density 1.457±0.06 g/cm3 (Predicted)
Appearance Slightly Yellow Powder
Boiling Point 1211.9±65.0°C (Predicted)
Excitation 400 nm
Emission 505 nm
Storage Store at -20°C
XLogP3 0.2
Hydrogen Bond Donor Count 8
Hydrogen Bond Acceptor Count 15
Rotatable Bond Count 18
Exact Mass 765.25813954 g/mol
Monoisotopic Mass 765.25813954 g/mol
Topological Polar Surface Area 275Ų
Heavy Atom Count 54
Formal Charge 0
Complexity 1480
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes
Publication Number Title Priority Date
US-2016058847-A1 IS100- A Highly Effective Enzyme Principle For Use In Dermal Therapeutics, And For Health And Beauty 2014-09-03
WO-2004100888-A2 N-thiolated azetidinones and anti-cancer use thereof 2003-05-06
US-2004167115-A1 Methods for preventing and treating cancer using N-thiolated beta-lactam compounds and analogs thereof 2002-05-06
US-2006160787-A1 Methods for preventing and treating cancer using N-thiolated beta-lactam compounds and analogs thereof 2002-05-06
US-7026472-B2 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof 2002-05-06

Recommended Services

Recommended Articles

Recommended Products

Online Inquiry

Verification code
cartIcon
Inquiry Basket